Cross-talk between CD8+ and CD4+ T cells in experimental cutaneous leishmaniasis: CD8+ T cells are required for optimal IFN-γ production by CD4+ T cells

Parasite Immunology

Volumn 25, Issue 11-12, 2003, Pages 559-567

  Herath, Shanthi ^a   Kropf, Pascale ^a   Müller, Ingrid ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Activation; CD8+ T cells; Cross talk; IFN ; Leishmania

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; OKT 4; OKT 8;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PARASITE; PRIORITY JOURNAL; SKIN LEISHMANIASIS; T LYMPHOCYTE;

ANIMALS; ANTILYMPHOCYTE SERUM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; INTERFERON TYPE II; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C;

ANIMALIA; LEISHMANIA MAJOR; PROTOZOA;

EID: 1842430012     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0141-9838.2004.00668.x     Document Type: Article

References (56)

1. Seder RA & Hill AVS. Vaccines against intracellular infections requiring cellular immunity. Nature, 2000; 406: 793-798.
2. Sacks DL & Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nature Rev Immunol, 2002; 2: 845-858.
3. Louis J, Himmelrich H, Parra-Lopez C, Tacchini-Cottier F & Launois P. Regulation of protective immunity against Leishmania major in mice. Curr Opin Immunol, 1998; 10: 459-464.
4. Reiner SL & Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol, 1995; 13: 151-177.
5. Mauel J, Ransijn A & Buchmüller-Rouiller Y. Killing of Leishmania parasites in activated murine macrophages is based on an 1-arginine-dependent process that produces nitrogen derivatives. J Leuk Biol, 1991; 49: 73-82.
6. Liew FY, Li Y, Moss D, Parkinson C, Rogers MV & Moncada S. Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur J Immunol, 1991; 21: 3009-3014.
7. Stenger S, Thuring H, Röllinghoff M & Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med, 1994; 180: 783-793.
8. Bogdan C. Nitric oxide and the immune response. Nature Immunol, 2001; 2: 907-916.
9. Loke P, MacDonald AS, Robb A, Maizels RM & Allen JE. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur J Immunol, 2000; 30: 2669-2678.
10. + T cells correlates with Th1/Th2 phenotype. J Immunol, 1998; 160: 5347-5354.
11. Gordon S. Alternative activation of macrophages. Nature Rev Immunol, 2003; 3: 23-35.
12. Loke P, Nair MG, Parkinson J, Guiliano D, Blaxter M & Allen JE. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol, 2002; 3: 7.
13. Müller I. Role of T cell subsets during the recall of immunologic memory to Leishmania major. Eur J Immunol, 1992; 22: 3063-3069.
14. + T cells. Infect Immun, 1993; 61: 3730-3738.
15. + T cells following secondary infection of mice immune to Leishmania major. Infect Immun, 1994; 62: 2575-2581.
16. + T cells in resistance to cutaneous leishmaniasis in immunized mice. J Immunol, 1989; 142: 2052-2056.
17. + T cells. J Immunol, 2000; 165: 915-924.
18. + T cell responses and protection against Leishmania major infection. J Exp Med, 2002; 195: 1565-1573.
19. + T lymphocyte activation. Vaccine, 2002; 20: 2439-2447.
20. Shah JA, Darrah PA, Ambrozak DR et al. Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice. J Exp Med, 2003; 198: 281-291.
21. + T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur J Immunol, 1987; 17: 1429-1433.
22. + T lymphocytes to mediate protective immunity against Leishmania. J Exp Med, 1989; 169: 1819-1827.
23. + T cells. Int Immunol, 1991; 3: 587-597.
24. + T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J Immunol 2002; 168: 3992-4000.
25. 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. J Immunol, 1993; 151: 2077-2086.
26. Huber M, Timms E, Mak TW, Röllinghoff M & Lohoff M. Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice. Infect Immun, 1998; 66: 3968-3970.
27. 2-microglobulin-deficient mice. Immunol Lett, 1993; 37: 13-17.
28. Titus RG, Ceredig RH, Cerottini JC & Louis JA. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically susceptible BALB/c mice. J Immunol, 1985; 135: 2108-2114.
29. Liew FY, Millott S, Lelchuck R, Cobbold S & Waldmann H. Effect of CD4 monoclonal antibody in vivo on lesion development, delayed-type hypersensitivity and interleukin 3 production in experimental murine cutaneous leishmaniasis. Clin Exp Immunol, 1989; 75: 438-443.
30. + T cells. J Immunol, 1987; 139: 1303-1309.
31. Müller I, Pedrazzini T, Farrell JP & Louis J. T-cell responses and immunity to experimental infection with Leishmania major. Annu Rev Immunol, 1989; 7: 561-578.
32. Kropf P, Brunson K, Etges R & Müller I. The Leishmaniasis model. In Immunology of Infection. Methods of Microbiology, Vol. 25. San Diego: Academic Press; 1998: 419-458.
33. Tough DF & Sprent J. Turnover of naive-and memory-phenotype T cells. J Exp Med, 1994; 179: 1127-1135.
34. Pala P, Hussell T & Openshaw PJM. Flow cytometric measurement of intracellular cytokines. J Immunol Meth, 2000; 243: 107-124.
35. Slade SS & Langhorne J. Production of interferon-γ during infection of mice with Plasmodium chabaudi chabaudi. Immunobiol, 1989; 179: 353-365.
36. Titus RG, Marchand M, Boon T & Louis JA. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol, 1985; 7: 545-555.
37. Kropf P, Etges R, Schopf L, Chung C, Sypek J & Müller I. Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous interleukin-4. J Immunol, 1997; 159: 3434-3443.
38. Park AY, Hondowicz BD & Scott P. IL-12 is required to maintain a Th1 response during Leishmania major infection. J Immunol, 2000; 165: 896-902.
39. + T cells are inducers and targets of nitric oxide produced by parasitized macrophages. Eur J Immunol, 1994; 24: 746-752.
40. Gurunathan S, Sacks DL, Brown DR et al. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J Exp Med, 1997; 186: 1137-1147.
41. Gurunathan S, Prussin C, Sacks DL & Seder RA. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nature Med, 1998; 4: 1409-1415.
42. Alce TM, Gokool S, McGhie D Stäger S & Smith DF. Expression of hydrophilic surface proteins in infective stages of Leishmania donovani. Mol Biochem Parasitol, 1999; 102: 191-196.
43. Shankar AH & Titus RG. T cell and non-T cell compartments can independently determine resistance to Leishmania major. J Exp Med, 1995; 181: 845-855.
44. H1 cell development. Science, 1996; 271: 984-987.
45. Hsieh C-S, Macatonia SE, O'Garra A & Murphy KM. T cell genetic background determines default T helper phenotype development in vitro. J Exp Med, 1995; 181: 713-721.
46. Pierres M Goridis C & Golstein P. Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94 000 and 180 000 molecular weight. Eur J Immunol, 1982; 12: 60-69.
47. Guermonprez P, Valladeau J, Zitvogel L, Théry C & Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol, 2002; 20: 621-667.
48. Betz-Corradin S, Fasel N, Buchmüller-Rouiller Y, Ransijn A, Smith J & Mauel J. Induction of macrophage nitric oxide production by interferon-γ and tumor necrosis factor-α is enhanced by interleukin-10. Eur J Immunol, 1993; 23: 2045-2048.
49. + T cell response. J Exp Med, 1995; 181: 961-971.
50. Liew FY & O'Donnell CA. Immunology of Leishmaniasis. Adv Parasitol, 1993; 32: 162-259.
51. Jones D, Elloso MM, Showe L, Williams D, Trinchieri G & Scott P. Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major. Infect Immun, 1998; 66: 3818-3824.
52. Mattner F, Di Padova K & Alber G. Interleukin-12 is indispensable for protective immunity against Leishmania major. Infect Immun, 1997; 65: 4378-4383.
53. + T cells associated with cure of human cutaneous leishmaniasis. Infect Immun, 1994; 62: 2614-2618.
54. Amaral VF, Pirmez C, Gonçalves A, Ferreira V & Grimaldi G Jr. Cell populations in lesions of cutaneous Leishmaniasis of Leishmania (L.) amazonensis-infected Rhesus Macaques, Macaca mulatta. Mem Inst Oswaldo Cruz, 2000; 95: 209-216.
55. Foucras G, Coudert JD, Coureau C & Guéry J-L. Dendritic cells prime in vivo alloreatice CD4 T lymphocytes toward Type 2 cytokine-and TGF-β-producing cells in the absence of CD8 T cell activation. J Immunol, 2000; 165: 4994-5003.
56. Modlin RL, Tapia FJ, Bloom BR et al. In situ characterization of the cellular immune response in American cutaneous leishmaniasis. Clin Exp Immunol, 1985; 60: 241-248.